269 related articles for article (PubMed ID: 18097594)
1. The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
Barbera M; Caputo A; Zampiron A; Gobbi S; Rampa A; Bisi A; Carrara M
Oncol Rep; 2008 Jan; 19(1):187-96. PubMed ID: 18097594
[TBL] [Abstract][Full Text] [Related]
2. Mono- or di-fluorinated analogues of flavone-8-acetic acid: synthesis and in vitro biological activity.
Carrara M; Zampiron A; Barbera M; Caputo A; Bisi A; Gobbi S; Belluti F; Piazzi L; Rampa A; Valenti P
Anticancer Res; 2005; 25(2A):1179-85. PubMed ID: 15868960
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of some analogues of flavone acetic acid.
Valenti P; Fabbri G; Rampa A; Bisi A; Gobbi S; Da Re P; Carrara M; Sgevano A; Cima L
Anticancer Drug Des; 1996 Apr; 11(3):243-52. PubMed ID: 8663911
[TBL] [Abstract][Full Text] [Related]
4. The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells.
Patel S; Parkin SM; Bibby MC
Anticancer Res; 1997; 17(1A):141-50. PubMed ID: 9066644
[TBL] [Abstract][Full Text] [Related]
5. Immune-modulating and anti-vascular activities of two xanthenone acetic acid analogues: A comparative study to DMXAA.
Barbera M; Kettunen MI; Caputo A; Hu DE; Gobbi S; Brindle KM; Carrara M
Int J Oncol; 2009 Jan; 34(1):273-9. PubMed ID: 19082498
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
Joseph WR; Cao Z; Mountjoy KG; Marshall ES; Baguley BC; Ching LM
Cancer Res; 1999 Feb; 59(3):633-8. PubMed ID: 9973211
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3-alkoxy analogues of flavone-8-acetic acid.
Gobbi S; Rampa A; Bisi A; Belluti F; Piazzi L; Valenti P; Caputo A; Zampiron A; Carrara M
J Med Chem; 2003 Aug; 46(17):3662-9. PubMed ID: 12904070
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
Baguley BC; Zhuang L; Kestell P
Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule cytokine inducers causing tumor necrosis.
Baguley BC
Curr Opin Investig Drugs; 2001 Jul; 2(7):967-75. PubMed ID: 11757800
[TBL] [Abstract][Full Text] [Related]
11. New derivatives of xanthenone-4-acetic acid: synthesis, pharmacological profile and effect on TNF-alpha and NO production by human immune cells.
Gobbi S; Belluti F; Bisi A; Piazzi L; Rampa A; Zampiron A; Barbera M; Caputo A; Carrara M
Bioorg Med Chem; 2006 Jun; 14(12):4101-9. PubMed ID: 16488613
[TBL] [Abstract][Full Text] [Related]
12. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
Ching LM; Joseph WR; Crosier KE; Baguley BC
Cancer Res; 1994 Feb; 54(4):870-2. PubMed ID: 8313372
[TBL] [Abstract][Full Text] [Related]
13. Flavone acetic acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes.
Futami H; Eader LA; Komschlies KL; Bull R; Gruys ME; Ortaldo JR; Young HA; Wiltrout RH
Cancer Res; 1991 Dec; 51(24):6596-602. PubMed ID: 1742732
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.
Thomsen LL; Ching LM; Baguley BC
Cancer Res; 1990 Nov; 50(21):6966-70. PubMed ID: 2170013
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.
Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM
Br J Cancer; 1999 May; 80(5-6):716-23. PubMed ID: 10360649
[TBL] [Abstract][Full Text] [Related]
16. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
Browne WL; Wilson WR; Baguley BC; Ching LM
Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
[TBL] [Abstract][Full Text] [Related]
17. Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancer.
Futami H; Hornung RL; Back TT; Bull R; Gruys E; Wiltrout RH
Cancer Res; 1990 Dec; 50(24):7926-31. PubMed ID: 2253233
[TBL] [Abstract][Full Text] [Related]
18. Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice.
Ching LM; Goldsmith D; Joseph WR; Körner H; Sedgwick JD; Baguley BC
Cancer Res; 1999 Jul; 59(14):3304-7. PubMed ID: 10416582
[TBL] [Abstract][Full Text] [Related]
19. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.
Thomsen LL; Ching LM; Zhuang L; Gavin JB; Baguley BC
Cancer Res; 1991 Jan; 51(1):77-81. PubMed ID: 1988109
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of flavone-2'-carboxylic acid analogues as potential antitumor agents.
Valenti P; Bisi A; Rampa A; Gobbi S; Belluti F; Da Re P; Cima L; Carrara M
Anticancer Drug Des; 1998 Dec; 13(8):881-92. PubMed ID: 10335265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
